Clinical Trials

Waldenstrom Macroglobulinemia, Recurrence

NCT05462639 2024-08-09

MAGNETISMM17

Multiple Myeloma, Recurrence

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Available

CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

NCT03153462 2023-11-08

ZUMA-9

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05131438 2023-03-27

An Expanded Access Program to Provide Sugemalimab for the Treatment of Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (R/R ENKTL)

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT04678466 2022-05-31

Flotetuzumab Expanded Access Program

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04162756 2021-10-14

ZUMA-18

Recurrence, Lymphoma, Mantle-Cell

NCT04705454 2021-05-12

Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01377532 2020-05-06

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

CNSEndocrine

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

NCT02568943 2020-04-08

An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma

Multiple Myeloma, Recurrence

NCT01632826 2019-11-12

PEXIUS

Multiple Myeloma, Recurrence

NCT02715843 2019-10-11

Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma

Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, B-Cell

NCT02437019 2017-03-20

Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02355054 2017-01-20

Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study

Genitourinary

Prostatic Neoplasms, Recurrence

NCT00423826 2016-02-29

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellSarcoma

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Leukemia, Erythroblastic, Acute, Hodgkin Disease, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT01432483 2015-01-26

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

Neoplasms, Recurrence

NCT00063791 2007-02-14

A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE